Thomas DL - Search Results

1

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Mehta SH, et al. Among authors: thomas dl. Hepatology. 2001 Jun;33(6):1554. doi: 10.1053/jhep.2001.0103306le01. Hepatology. 2001. PMID: 11391549 No abstract available.

2

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Sulkowski MS, et al. Among authors: thomas dl. JAMA. 2000 Jan 5;283(1):74-80. doi: 10.1001/jama.283.1.74. JAMA. 2000. PMID: 10632283

3

Determinants of the quantity of hepatitis C virus RNA.

Thomas DL, Astemborski J, Vlahov D, Strathdee SA, Ray SC, Nelson KE, Galai N, Nolt KR, Laeyendecker O, Todd JA. Thomas DL, et al. J Infect Dis. 2000 Mar;181(3):844-51. doi: 10.1086/315314. J Infect Dis. 2000. PMID: 10720503

4

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.

Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. Clin Infect Dis. 2000 Apr;30 Suppl 1:S77-84. doi: 10.1086/313842. Clin Infect Dis. 2000. PMID: 10770916 Review.

5

The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. Thomas DL, et al. JAMA. 2000 Jul 26;284(4):450-6. doi: 10.1001/jama.284.4.450. JAMA. 2000. PMID: 10904508

6

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Mehta SH, et al. Among authors: thomas dl. Ann Intern Med. 2000 Oct 17;133(8):592-9. doi: 10.7326/0003-4819-133-8-200010170-00009. Ann Intern Med. 2000. PMID: 11033586

7

Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies.

Mao Q, Ray SC, Laeyendecker O, Ticehurst JR, Strathdee SA, Vlahov D, Thomas DL. Mao Q, et al. Among authors: thomas dl. J Virol. 2001 Apr;75(7):3259-67. doi: 10.1128/JVI.75.7.3259-3267.2001. J Virol. 2001. PMID: 11238852 Free PMC article.

8

Dynamics of SEN virus infection among injection drug users.

Wilson LE, Umemura T, Astemborski J, Ray SC, Alter HJ, Strathdee SA, Vlahov D, Thomas DL. Wilson LE, et al. Among authors: thomas dl. J Infect Dis. 2001 Nov 15;184(10):1315-9. doi: 10.1086/324001. Epub 2001 Oct 2. J Infect Dis. 2001. PMID: 11679921

9

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Sulkowski MS, et al. Among authors: thomas dl. Hepatology. 2002 Jan;35(1):182-9. doi: 10.1053/jhep.2002.30319. Hepatology. 2002. PMID: 11786975

10

Peripheral blood count abnormalities among patients with hepatitis C in the United States.

Streiff MB, Mehta S, Thomas DL. Streiff MB, et al. Among authors: thomas dl. Hepatology. 2002 Apr;35(4):947-52. doi: 10.1053/jhep.2002.32486. Hepatology. 2002. PMID: 11915043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

766 results

Search Page

Filters